Biolinq
Venture Round in 2024
Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors for health monitoring. Founded in 2012, Biolinq focuses on creating a digital health platform that offers minimally invasive electrochemical biosensors. These sensors analyze biomarkers in interstitial fluid to deliver actionable health information, particularly for diabetic patients who need to monitor their blood glucose levels. By enabling continuous monitoring of multiple biomarkers, the company's technology aims to improve metabolic health and provide a more convenient alternative to traditional blood glucose monitoring methods.
iAnthus Capital Holdings, Inc. is involved in the cannabis industry through its subsidiary, iAnthus Capital Management, LLC. The company offers investors diversified exposure to licensed cannabis cultivators, processors, and dispensaries across the United States. iAnthus has established ownership, operational control, or partnerships with marijuana license holders in several states, including Massachusetts, Vermont, Colorado, and New Mexico. By combining financial resources with operational expertise, iAnthus aims to support the growth of its partners in the legal cannabis market.
WATT Fuel Cell
Venture Round in 2022
WATT Fuel Cell Corporation is a developer and manufacturer of solid oxide fuel cell (SOFC) systems and components, based in Mount Pleasant, Pennsylvania. Founded in 2010, the company specializes in creating fuel cells that operate on readily available hydrocarbon fuels, including natural gas, propane, JP-8, and diesel. WATT's technology is designed to provide efficient, clean, and environmentally responsible energy solutions for various sectors, including marine and recreational vehicles, emergency response, military, and remote power applications. The company offers a hybrid SOFC system that integrates hydrocarbon fuels with renewable energy sources like solar and wind, optimizing power output and energy storage. Its modular design allows for scalable solutions, enabling clients to increase power capacity by adding additional modules as needed, similar to a blade server configuration.
Tasso, Inc., established in 2012 and based in Seattle, Washington, specializes in manufacturing clinical-grade, at-home blood sample collection devices. Their innovative product allows patients to conveniently and painlessly collect their own blood at home using a simple, push-button mechanism, and then mail the samples to a qualified lab for analysis. This approach aims to enhance accessibility and comfort in blood-based diagnostics, reducing the need for clinic visits.
Biolinq Inc. is a San Diego-based company that specializes in developing skin-applied electronic sensors for health monitoring. Founded in 2012, Biolinq focuses on creating a digital health platform that offers minimally invasive electrochemical biosensors. These sensors analyze biomarkers in interstitial fluid to deliver actionable health information, particularly for diabetic patients who need to monitor their blood glucose levels. By enabling continuous monitoring of multiple biomarkers, the company's technology aims to improve metabolic health and provide a more convenient alternative to traditional blood glucose monitoring methods.
Redwire, LLC specializes in the design, development, and manufacturing of spacecraft architecture and components. Founded in 2002 and based in Fulton, Maryland, the company emphasizes space commercialization and digitally engineered spacecraft. Redwire offers a range of services, including supply chain security assessments, anti-tamper engineering and packaging, deployment, and maintenance. The company aims to accelerate humanity's advancement into space by providing reliable and cost-effective infrastructure for future generations, with a focus on on-orbit services, assembly, and manufacturing. Redwire was formerly known as Adcole Maryland Aerospace before its name change in June 2020 following a merger with Deep Space Systems.
Otonomo Technologies
Post in 2021
Otonomo Technologies Ltd. operates a cloud-based marketplace that connects cars to services and applications, facilitating the collection and delivery of vehicle data for enhanced safety and in-car experiences. The company, founded in 2015 and headquartered in Herzliya, Israel, with offices in Redwood City, California, and Frankfurt, Germany, securely processes over 4 billion data points daily from more than 40 million vehicles. Otonomo's platform enables original equipment manufacturers (OEMs), fleet operators, and over 100 service providers to access and utilize this data, accelerating the development of new services that improve driver experiences and support smart city initiatives. The company prioritizes privacy and neutrality, ensuring compliance with global data protection regulations.
Rockley Photonics
Post in 2021
Rockley Photonics Limited is a London-based company founded in 2013 that specializes in silicon photonics for various applications. The company develops a comprehensive range of photonic integrated circuits, sensors, and full-stack solutions aimed at high-volume markets. Rockley's technology is designed for next-generation sensing platforms, including mobile health monitoring and machine vision, as well as for high-speed data communications. By focusing on integrated optical modules, supporting electronics, software, and AI platforms, Rockley aims to establish a strong presence in dynamic and rapidly growing sectors. The company envisions photonics becoming as ubiquitous as microelectronics, leveraging its versatile platform to address diverse market needs.
WM Technology
Post in 2021
WM Technology provides the broadest suite of cloud-based software as a service (SaaS) and data solutions for the cannabis industry. WM Technology’s product suite includes point of sale, logistics, wholesale, and ordering solutions that enable clients to scale their businesses while complying with the complex and disparate regulations applicable to the cannabis industry.
AIStorm, Inc. is a technology company specializing in the development and manufacturing of microchips, particularly focusing on AI-in-sensor system-on-chips (SoCs) for the semiconductor industry. The company offers a range of products, including the Mantis family of AI-in-imager and AI-in-audio chips, as well as MantisNet AI videos. These products are utilized in various applications such as fingerprint sensors, augmented transportation, security cameras, gesture control, food service automation, medical imaging, and edge voice processing. Founded in 2011 and headquartered in San Jose, California, AIStorm employs advanced analog and mixed-signal technology to enable sensors to process data directly from devices, minimizing latency, power consumption, and costs. The company's innovative approach allows sensors to interface seamlessly with convolutional neural networks, enhancing performance for edge computing applications. AIStorm also maintains offices in locations including Houston, Texas, Cleveland, Ohio, Silicon Valley, California, and several international sites.
Pharmacopeia
Venture Round in 2005
Pharmacopeia, Inc. is a biopharmaceutical company focused on the discovery and development of therapeutics for unmet medical needs. The company's internal program portfolio includes PS433540, a dual-acting angiotensin and endothelin receptor antagonist currently in phase II clinical development for cardiovascular and renal diseases, such as hypertension and diabetic nephropathy. Additionally, PS178990, a muscle selective SARM agonist, is in phase I clinical development. Pharmacopeia also has a preclinical product, PS031291, aimed at treating multiple myeloma and inflammatory diseases like rheumatoid arthritis, as well as JAK3 inhibitors targeting T-cell and cytokine mediated dermatologic and ocular conditions, including psoriasis and dry eye. The company has formed strategic alliances with several pharmaceutical firms, enhancing its research and development capabilities. Founded in 1993 and based in Cranbury, New Jersey, Pharmacopeia was previously known as Pharmacopeia Drug Discovery, Inc. and became a subsidiary of Ligand Pharmaceuticals Inc. in 2008.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.